372
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart

, , , , , , , & show all
Pages 54-63 | Received 19 Aug 2009, Accepted 03 Nov 2009, Published online: 22 Feb 2010
 

Abstract

Dyxin is a novel LIM domain protein acting as a transcriptional cofactor with GATA transcription factors. Here, we characterized dyxin as a p38 mitogen-activated protein kinase (MAPK) regulated gene, since combined upstream MAPK kinase 3b and wild-type p38α MAPK gene transfer increased left ventricular dyxin mRNA and protein levels in vivo. We also studied cardiac dyxin expression in experimental models of pressure overload and myocardial infarction (MI) in vivo. Angiotensin II infusion increased left ventricular dyxin mRNA levels (9.4-fold, p<0.001) rapidly at 6 h followed by induction of protein levels. Furthermore, simultaneous administration of p38 MAPK inhibitor SB203580 abolished angiotensin II-induced activation of dyxin gene expression. During the post-infarction remodeling process, increased dyxin mRNA levels (7.7-fold, p<0.01) were noted at day 1 followed by the increase in proteins levels at 2 weeks after MI (1.5-fold, p<0.05). Moreover, direct wall stretch by using isolated rat heart preparation as well as direct mechanical stretch of cardiomyocytes in vitro activated dyxin gene expression within 1 h. Our results indicate that dyxin expression is rapidly upregulated in response to mechanical load, this increase being at least partly mediated by p38 MAPK. These results suggest that dyxin may play an important role in regulating hypertrophic process.

Acknowledgments

We thank Marja Arbelius, Pirjo Korpi, Kaisa Penttilä, Sirpa Rutanen, Erja Tomperi, Mirja Vahera and Kati Viitala for expert technical assistance.

Funding

This study was supported by the Academy of Finland, the Finnish Foundation of Cardiovascular Research, the Sigrid Jusélius Foundation and the Research and Science Foundation of Farmos.

Declaration of interest: The authors have no conflicts of interest that are directly relevant to the content of this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.